Oral Paclitaxel Combo Shows Higher Response Rate Than IV Paclitaxel in Breast Cancer

A phase 3 study evaluated the safety and efficacy of oral paclitaxel versus intravenous paclitaxel monotherapy in patients with metastatic breast cancer.
— Read on www.specialtypharmacytimes.com/

Oral therapies are still effective…..